Efficient siRNA delivery into tumor cells by p19-YSA fusion protein

Kyung Mi Choi, Ggon Lip Park, Kwang Yeon Hwang, Jeong Won Lee, Hyung Jun Ahn

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

For the efficient cytoplasmic delivery of siRNA in a receptor-specific fashion, we designed a p19-YSA fusion protein composed of p19 RNA binding protein and ephrin mimetic peptide (YSA peptide). The resulting recombinant protein had the high affinity for EphA2 receptor overexpressed on cancer cells as well as the complexing ability with siRNA, thus leading to tumor-targeted delivery of siRNA. The buried structure of siRNA within p19-YSA/siRNA complexes allowed the bound siRNAs to be protected from the external RNases, resulting in the enhanced stability of siRNA in serum conditions. The p19-YSA carriers could complex with siRNA in a size-dependent and sequence-independent manner and showed the pH-dependent complexing/dissocation behaviors with siRNA. In contrast to electrostatic interaction-mediated siRNA delivery systems such as cationic polymers/siRNA or cationic polypeptides/siRNA complexes, the bound siRNA within p19-YSA/siRNA complexes showed enhanced stability against large polyanions found outside cells, due to the nanomolar levels of affinity. Here, we demonstrated the superior efficiency of p19-YSA/siRNA complexes in RFP gene silencing, compared to untreated cells. These results provide an alternative approach to enhance the stability of siRNA as well as to achieve the targeted siRNA delivery.

Original languageEnglish
Pages (from-to)763-773
Number of pages11
JournalMolecular Pharmaceutics
Volume10
Issue number2
DOIs
Publication statusPublished - 2013 Feb 4

Fingerprint

Small Interfering RNA
Neoplasms
Proteins
Peptides
EphA2 Receptor
Ephrins
RNA-Binding Proteins
Gene Silencing
Ribonucleases
Static Electricity
Recombinant Proteins
Polymers

Keywords

  • cytoplasmic delivery
  • ephrin mimetic peptide
  • recombinant protein
  • siRNA
  • tumor targeting

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Molecular Medicine
  • Drug Discovery

Cite this

Efficient siRNA delivery into tumor cells by p19-YSA fusion protein. / Choi, Kyung Mi; Park, Ggon Lip; Hwang, Kwang Yeon; Lee, Jeong Won; Ahn, Hyung Jun.

In: Molecular Pharmaceutics, Vol. 10, No. 2, 04.02.2013, p. 763-773.

Research output: Contribution to journalArticle

Choi, Kyung Mi ; Park, Ggon Lip ; Hwang, Kwang Yeon ; Lee, Jeong Won ; Ahn, Hyung Jun. / Efficient siRNA delivery into tumor cells by p19-YSA fusion protein. In: Molecular Pharmaceutics. 2013 ; Vol. 10, No. 2. pp. 763-773.
@article{9336a42b55e347fda9261f75f18d284a,
title = "Efficient siRNA delivery into tumor cells by p19-YSA fusion protein",
abstract = "For the efficient cytoplasmic delivery of siRNA in a receptor-specific fashion, we designed a p19-YSA fusion protein composed of p19 RNA binding protein and ephrin mimetic peptide (YSA peptide). The resulting recombinant protein had the high affinity for EphA2 receptor overexpressed on cancer cells as well as the complexing ability with siRNA, thus leading to tumor-targeted delivery of siRNA. The buried structure of siRNA within p19-YSA/siRNA complexes allowed the bound siRNAs to be protected from the external RNases, resulting in the enhanced stability of siRNA in serum conditions. The p19-YSA carriers could complex with siRNA in a size-dependent and sequence-independent manner and showed the pH-dependent complexing/dissocation behaviors with siRNA. In contrast to electrostatic interaction-mediated siRNA delivery systems such as cationic polymers/siRNA or cationic polypeptides/siRNA complexes, the bound siRNA within p19-YSA/siRNA complexes showed enhanced stability against large polyanions found outside cells, due to the nanomolar levels of affinity. Here, we demonstrated the superior efficiency of p19-YSA/siRNA complexes in RFP gene silencing, compared to untreated cells. These results provide an alternative approach to enhance the stability of siRNA as well as to achieve the targeted siRNA delivery.",
keywords = "cytoplasmic delivery, ephrin mimetic peptide, recombinant protein, siRNA, tumor targeting",
author = "Choi, {Kyung Mi} and Park, {Ggon Lip} and Hwang, {Kwang Yeon} and Lee, {Jeong Won} and Ahn, {Hyung Jun}",
year = "2013",
month = "2",
day = "4",
doi = "10.1021/mp300344p",
language = "English",
volume = "10",
pages = "763--773",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Efficient siRNA delivery into tumor cells by p19-YSA fusion protein

AU - Choi, Kyung Mi

AU - Park, Ggon Lip

AU - Hwang, Kwang Yeon

AU - Lee, Jeong Won

AU - Ahn, Hyung Jun

PY - 2013/2/4

Y1 - 2013/2/4

N2 - For the efficient cytoplasmic delivery of siRNA in a receptor-specific fashion, we designed a p19-YSA fusion protein composed of p19 RNA binding protein and ephrin mimetic peptide (YSA peptide). The resulting recombinant protein had the high affinity for EphA2 receptor overexpressed on cancer cells as well as the complexing ability with siRNA, thus leading to tumor-targeted delivery of siRNA. The buried structure of siRNA within p19-YSA/siRNA complexes allowed the bound siRNAs to be protected from the external RNases, resulting in the enhanced stability of siRNA in serum conditions. The p19-YSA carriers could complex with siRNA in a size-dependent and sequence-independent manner and showed the pH-dependent complexing/dissocation behaviors with siRNA. In contrast to electrostatic interaction-mediated siRNA delivery systems such as cationic polymers/siRNA or cationic polypeptides/siRNA complexes, the bound siRNA within p19-YSA/siRNA complexes showed enhanced stability against large polyanions found outside cells, due to the nanomolar levels of affinity. Here, we demonstrated the superior efficiency of p19-YSA/siRNA complexes in RFP gene silencing, compared to untreated cells. These results provide an alternative approach to enhance the stability of siRNA as well as to achieve the targeted siRNA delivery.

AB - For the efficient cytoplasmic delivery of siRNA in a receptor-specific fashion, we designed a p19-YSA fusion protein composed of p19 RNA binding protein and ephrin mimetic peptide (YSA peptide). The resulting recombinant protein had the high affinity for EphA2 receptor overexpressed on cancer cells as well as the complexing ability with siRNA, thus leading to tumor-targeted delivery of siRNA. The buried structure of siRNA within p19-YSA/siRNA complexes allowed the bound siRNAs to be protected from the external RNases, resulting in the enhanced stability of siRNA in serum conditions. The p19-YSA carriers could complex with siRNA in a size-dependent and sequence-independent manner and showed the pH-dependent complexing/dissocation behaviors with siRNA. In contrast to electrostatic interaction-mediated siRNA delivery systems such as cationic polymers/siRNA or cationic polypeptides/siRNA complexes, the bound siRNA within p19-YSA/siRNA complexes showed enhanced stability against large polyanions found outside cells, due to the nanomolar levels of affinity. Here, we demonstrated the superior efficiency of p19-YSA/siRNA complexes in RFP gene silencing, compared to untreated cells. These results provide an alternative approach to enhance the stability of siRNA as well as to achieve the targeted siRNA delivery.

KW - cytoplasmic delivery

KW - ephrin mimetic peptide

KW - recombinant protein

KW - siRNA

KW - tumor targeting

UR - http://www.scopus.com/inward/record.url?scp=84873363217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873363217&partnerID=8YFLogxK

U2 - 10.1021/mp300344p

DO - 10.1021/mp300344p

M3 - Article

C2 - 23276207

AN - SCOPUS:84873363217

VL - 10

SP - 763

EP - 773

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 2

ER -